Task: Answer the multiple choice question.
Query: Which drug has a 6.702\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CC(=NCCCNC1CCCCC1)C1=C(O)CC(C)(C)CC1=O
b: CN(CC(=O)NCc1ccccn1)S(=O)(=O)c1cc(Cl)ccc1Cl
c: CCCCN(C(=O)CSc1nc2ccccc2n1CC)C1CCS(=O)(=O)C1
Answer: c. CCCCN(C(=O)CSc1nc2ccccc2n1CC)C1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C(=O)CSc1nc2ccccc2n1CC)C1CCS(=O)(=O)C1
CCCCN(C(=O)CSc1nc2ccccc2n1CC)C1CCS(=O)(=O)C1
N-butyl-N-(1,1-dioxothiolan-3-yl)-2-(1-ethylbenzimidazol-2-yl)sulfanylacetamide